Barclays Maintains Overweight on Intuitive Surgical, Raises Price Target to $490
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Matt Miksic maintains an Overweight rating on Intuitive Surgical (NASDAQ:ISRG) and raises the price target from $430 to $490.
July 18, 2024 | 3:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Matt Miksic maintains an Overweight rating on Intuitive Surgical and raises the price target from $430 to $490.
The raised price target and maintained Overweight rating from a reputable analyst at Barclays is likely to positively impact Intuitive Surgical's stock price in the short term as it reflects strong confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100